Search Results

LabConnect, Inc. is pleased to announce the appointment of Ms. Dawn Sherman to serve as its Chief Executive Officer and member of the Board of Directors.

LabConnect Inc., a leading global provider of central laboratory and functional outsourcing services for biopharmaceutical, pharmaceutical, medical device, and contract research organizations, today announced that the company is expanding its operations into Europe with the appointment of Marc van Kempen as General Manager Europe.

LabConnect, a leading global provider of central laboratory and support services for the biopharmaceutical industry, today announced a major expansion of its Johnson City facility. In response to unprecedented demand for LabConnect’s services for cell and gene therapies, immuno-oncology, and other advanced therapeutics,

LabConnect, Inc. and Cryoport, Inc. (NASDAQ: CYRX) today announced a partnership to provide comprehensive logistics support for an upcoming Phase I/II clinical trial sponsored by Triumvira Immunologics Inc., a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers.

LabConnect, a leading global provider of central laboratory and support services for biopharmaceutical, medical device and contract research organizations, today announced the appointment of Sam Osman to its Board of Directors.

LabConnect, the preeminent provider of clinical trial central lab services, announced the expansion of its Johnson City facility to support its significant growth in cell and gene therapy and immuno-oncology studies.

LabConnect, a leading global provider of central laboratory and support services for biopharmaceutical, medical device, and contract research organizations, is pleased to announce a new service: LabConnect’s global sample processing network (GSPN).

Jeff Mayhew, LabConnect’s Chief Development Officer, took time to speak with BioSpace about the company and the Seattle area. Mayhew is also one of the founders of LabConnect, which was started in 2002 and relocated to Seattle in 2004.

CORRECTION...by LabConnect, LLC